Villablanca, J. G., Maris, J. M., Stambler, N., Zhou, D., DiPippo, V. A., & Matthay, K. K. (2020). SAT-163 Status at 10 Years: Long-Term Follow-Up for a Phase 2a Study of High-Specific-Activity (HSA) I 131 Iobenguane in Patients (Pts) with Relapsed/Refractory High-Risk Neuroblastoma. J Endocr Soc.
Chicago-stil citatVillablanca, Judith G., John M. Maris, Nancy Stambler, Duo Zhou, Vincent A. DiPippo, och Katherine K. Matthay. "SAT-163 Status At 10 Years: Long-Term Follow-Up for a Phase 2a Study of High-Specific-Activity (HSA) I 131 Iobenguane in Patients (Pts) With Relapsed/Refractory High-Risk Neuroblastoma." J Endocr Soc 2020.
MLA-referensVillablanca, Judith G., et al. "SAT-163 Status At 10 Years: Long-Term Follow-Up for a Phase 2a Study of High-Specific-Activity (HSA) I 131 Iobenguane in Patients (Pts) With Relapsed/Refractory High-Risk Neuroblastoma." J Endocr Soc 2020.